Self-care management in a diabetic patient requires skills to make essential changes in routine day-to-day activities for controlling the disease and improving the quality of life in a natural way.
BOS-580 treatment improved markers of glycemic control and reduced liver steatosis across diabetic sub-populations with phenotypic NASHAdditional data support the continued development of BOS-580 once-monthly dosingCAMBRIDGE, Mass. (BUSINESS WIRE) Boston Pharmaceuticals, a clinical-stage biopharmaceutical company.
Boston Pharmaceuticals To Present New Phase 2a Data From Investigational BOS-580 NASH Program at AASLD The Liver Meeting® 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.